Krishna Institute of Medical Sciences Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹997.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.85 per cent from ₹960.70 crore. This corresponds to a year-on-year *(YoY) growth of 29.17 per cent.
Operating Profit
Operating Profit stands at ₹198.90 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.36 per cent from ₹203.70 crore. This corresponds to a year-on-year *(YoY) growth of 6.25 per cent.
PBDT
PBDT stands at ₹147.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.58 per cent from ₹162.90 crore. This corresponds to a year-on-year *(YoY) decline of 17.85 per cent.
Profit Before Tax
Profit Before Tax stands at ₹68.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 29.13 per cent from ₹96.80 crore. This corresponds to a year-on-year *(YoY) decline of 49.03 per cent.
Net Profit
Net Profit stands at ₹51.90 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 27.92 per cent from ₹72.00 crore. This represents a 43.89 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Krishna Institute of Medical Sciences Ltd Earnings
- YOY
- QOQ
Krishna Institute of Medical Sciences Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Krishna Institute of Medical Sciences Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Krishna Institute of Medical Sciences Ltd Financial Reports
Krishna Institute of Medical Sciences Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Krishna Institu. | -0.71% | -1.75% | 15.16% | 11.83% | 14.64% | 19.77% |
| Aster DM Health. | 1.56% | 2.59% | 12.42% | 22.34% | 11.67% | 28.70% |
| Narayana Hrudaya | 1.50% | -1.76% | 4.59% | 1.00% | -4.81% | 4.69% |
| Global Health | 2.45% | 0.07% | 13.35% | 8.30% | 4.19% | 3.11% |
| Dr Lal Pathlabs | -0.38% | -3.78% | 12.55% | 11.72% | 0.64% | 13.48% |
| Syngene Intl. | -3.54% | -5.83% | 4.52% | 4.45% | -29.32% | -29.57% |
| Poly Medicure | -3.37% | -9.47% | -0.25% | 14.76% | -21.33% | -38.23% |
Company Info
Company Information
CMD & Director. : Bhaskara Rao Bollineni
Executive Director & CEO : Abhinay Bollineni
WTD & Executive Director : Dandamudi Anitha
Non Executive Director : Adwik Bollineni
Independent Non Exe. Director : Saumen Chakraborty
Independent Non Exe. Director : Ratna Kishore Kaza
Independent Non Exe. Director : J V Ramudu
Independent Non Exe. Director : Y Prameela Rani
Independent Non Exe. Director : Suresh Natwarlal Patel
Company Sec. & Compli. Officer : Nagajayanthi Raghavendra Das Juttur